Next Century Growth Investors LLC Makes New $3 Million Investment in Billiontoone, Inc. $BLLN

Next Century Growth Investors LLC purchased a new position in Billiontoone, Inc. (NASDAQ:BLLN) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 36,659 shares of the company’s stock, valued at approximately $3,000,000.

Several other institutional investors and hedge funds have also bought and sold shares of BLLN. Rossby Financial LCC purchased a new position in Billiontoone in the fourth quarter worth $25,000. Wells Fargo & Company MN purchased a new position in Billiontoone in the fourth quarter worth $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone in the fourth quarter worth $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Billiontoone during the fourth quarter worth $82,000. Finally, Renaissance Capital LLC purchased a new stake in shares of Billiontoone during the fourth quarter valued at $201,000.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. BTIG Research dropped their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Guggenheim boosted their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. JPMorgan Chase & Co. boosted their price objective on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Finally, Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, June 5th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Billiontoone currently has a consensus rating of “Moderate Buy” and a consensus target price of $125.29.

Insiders Place Their Bets

In other Billiontoone news, insider Oguzhan Atay sold 26,250 shares of the company’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $97.66, for a total value of $2,563,575.00. Following the completion of the transaction, the insider owned 20,000 shares in the company, valued at approximately $1,953,200. This represents a 56.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $98.22, for a total transaction of $785,760.00. Following the completion of the transaction, the insider owned 212,000 shares of the company’s stock, valued at approximately $20,822,640. This trade represents a 3.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 60,750 shares of company stock worth $5,979,598.

Billiontoone Stock Performance

NASDAQ BLLN opened at $101.12 on Monday. The company has a fifty day moving average of $88.03 and a 200 day moving average of $87.97. The company has a market capitalization of $4.65 billion and a PE ratio of 183.85. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $138.70. The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. The company’s revenue was up 83.8% on a year-over-year basis. During the same quarter last year, the company posted ($0.39) EPS. Research analysts forecast that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.